NovaBridge Biosciences (NBP) Retained Earnings (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Retained Earnings for 8 consecutive years, with -$1.3 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Retained Earnings fell 3.6% year-over-year to -$1.3 billion; the TTM figure through Dec 2025 stood at -$1.3 billion (down 3.6% YoY), while the FY2025 annual figure was -$1.3 billion, down 3.6% from the prior year.
• Retained Earnings fell to -$1.3 billion in Q4 2025 per NBP's latest filing, from -$1.3 billion in the prior quarter.
• Across five years, Retained Earnings topped out at -$480.1 million in Q2 2021 and bottomed at -$681.1 billion in Q4 2021.
• Historically, Retained Earnings has averaged -$53.4 billion across 5 years, with a median of -$1.3 billion in 2024.
• Annual changes were most pronounced in 2021 — Retained Earnings slumped 223003.5% — and 2022, when it soared 99.86%.
• NovaBridge Biosciences' Retained Earnings stood at -$681.1 billion in 2021, then jumped by 99.86% to -$964.8 million in 2022, then retreated by 19.88% to -$1.2 billion in 2023, then fell by 11.19% to -$1.3 billion in 2024, then slipped by 3.6% to -$1.3 billion in 2025.
• Business Quant data shows NBP's Retained Earnings at -$1.3 billion in Q4 2025, -$1.3 billion in Q3 2025, and -$1.3 billion in Q2 2025.